Broussonin E - CAS 90902-21-9

Broussonin E could suppress inflammation by modulating macrophages activation state via inhibiting the ERK and p38 MAPK and enhancing JAK2-STAT3 signaling pathway, and can be further developed as a promising drug for the treatment of inflammation-related diseases such as atherosclerosis.

ERK, STAT, COX, JAK, Arginase, p38 MAPK, Interleukin, TNF

Angiogenesis, MAPK, JAK/STAT signaling, Tyrosine Kinase/Adaptors, Chromatin/Epigenetic, Neuroscience, Stem Cells, Immunology/Inflammation, Apoptosis

90902-21-9

C17H20O4

288.34

COc1ccc(CCCc2ccc(OC)c(O)c2)c(O)c1

-20°C

Ice Packs

Natural Product